Answer
Lemtrada (alemtuzumab) infusion-associated reactions, such as dizziness, occur during or within 24 hours after treatment and may temporarily impair driving or machine use, so caution should be exercised until they resolve.
Sources for this answer
- LEMTRADA 12 mg concentrate for solution for infusionSANOFI · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 3Document updated
Sources checked